 | Up a level |
Attard, Gerhardt; Murphy, Laura; Clarke, Noel W; Cross, William; Jones, Robert J; Parker, Christopher C; Gillessen, Silke; Cook, Adrian; Brawley, Chris; Amos, Claire L; Atako, Nafisah; Pugh, Cheryl; Buckner, Michelle; Chowdhury, Simon; Malik, Zafar; Russell, J Martin; Gilson, Clare; Rush, Hannah; Bowen, Jo; Lydon, Anna; ... (2022). Abiraterone acetate and prednisolone with or without enzalutamide for high-risk non-metastatic prostate cancer: a meta-analysis of primary results from two randomised controlled phase 3 trials of the STAMPEDE platform protocol. The lancet, 399(10323), pp. 447-460. Elsevier 10.1016/S0140-6736(21)02437-5
Guo, Christina; Crespo, Mateus; Gurel, Bora; Dolling, David; Rekowski, Jan; Sharp, Adam; Petremolo, Antonella; Sumanasuriya, Semini; Rodrigues, Daniel N; Ferreira, Ana; Pereira, Rita; Figueiredo, Ines; Mehra, Niven; Lambros, Maryou B K; Neeb, Antje; Gil, Veronica; Seed, George; Terstappen, Leon; Alimonti, Andrea; Drake, Charles G; ... (2021). CD38 in Advanced Prostate Cancers. European urology, 79(6), pp. 736-746. Elsevier 10.1016/j.eururo.2021.01.017
Hoyle, Alex P; Ali, Adnan; James, Nicholas D; Cook, Adrian; Parker, Christopher C; de Bono, Johann S; Attard, Gerhardt; Chowdhury, Simon; Cross, William R; Dearnaley, David P; Brawley, Christopher D; Gilson, Clare; Ingleby, Fiona; Gillessen, Silke; Aebersold, Daniel; Jones, Rob J; Matheson, David; Millman, Robin; Mason, Malcolm D; Ritchie, Alastair W S; ... (2019). Abiraterone in "High-" and "Low-risk" Metastatic Hormone-sensitive Prostate Cancer. European urology, 76(6), pp. 719-728. Elsevier 10.1016/j.eururo.2019.08.006
Boysen, Gunther; Rodrigues, Daniel N; Rescigno, Pasquale; Seed, George; Dolling, David; Riisnaes, Ruth; Crespo, Mateus; Zafeiriou, Zafeiris; Sumanasuriya, Semini; Bianchini, Diletta; Hunt, Joanne; Moloney, Deirdre; Perez-Lopez, Raquel; Tunariu, Nina; Miranda, Susana; Figueiredo, Inês; Ferreira, Ana; Christova, Rossitza; Gil, Veronica; Aziz, Sara; ... (2018). SPOP-Mutated/CHD1-Deleted Lethal Prostate Cancer and Abiraterone Sensitivity. Clinical cancer research, 24(22), pp. 5585-5593. American Association for Cancer Research 10.1158/1078-0432.CCR-18-0937
Mateo, Joaquin; Cheng, Heather H; Beltran, Himisha; Dolling, David; Xu, Wen; Pritchard, Colin C; Mossop, Helen; Rescigno, Pasquale; Perez-Lopez, Raquel; Sailer, Verena; Kolinsky, Michael; Balasopoulou, Ada; Bertan, Claudia; Nanus, David M; Tagawa, Scott T; Thorne, Heather; Montgomery, Bruce; Carreira, Suzanne; Sandhu, Shahneen; Rubin, Mark Andrew; ... (2018). Clinical Outcome of Prostate Cancer Patients with Germline DNA Repair Mutations: Retrospective Analysis from an International Study. European urology, 73(5), pp. 687-693. Elsevier 10.1016/j.eururo.2018.01.010
Gillessen, Silke; de Bono, Johann S; Sartor, Oliver; Omlin, Aurelius Gabriel (2018). Reply to Finn E. von Eyben, Irene Virgolini and Giandomenico Roviello's Letter to the Editor re: Silke Gillessen, Gerhardt Attard, Tomasz M. Beer, et al. Management of Patients with Advanced Prostate Cancer: The Report of the Advanced Prostate Cancer Consensus Conference APCCC 2017. Eur Urol 2018;73:178-211. European urology, 73(2), e32-e33. Elsevier 10.1016/j.eururo.2017.08.014
Mateo, Joaquin; Boysen, Gunther; Barbieri, Christopher E; Bryant, Helen E; Castro, Elena; Nelson, Pete S; Olmos, David; Pritchard, Colin C; Rubin, Mark Andrew; de Bono, Johann S (2017). DNA Repair in Prostate Cancer: Biology and Clinical Implications. European urology, 71(3), pp. 417-425. Elsevier 10.1016/j.eururo.2016.08.037
Attard, Gerhardt; Sydes, Matthew R; Mason, Malcolm D; Clarke, Noel W; Aebersold, Daniel; de Bono, Johann S; Dearnaley, David P; Parker, Chris C; Ritchie, Alastair W S; Russell, J Martin; Thalmann, George; Cassoly, Estelle; Millman, Robin; Matheson, David; Schiavone, Francesca; Spears, Melissa R; Parmar, Mahesh K B; James, Nicholas D (2014). Combining Enzalutamide with Abiraterone, Prednisone, and Androgen Deprivation Therapy in the STAMPEDE Trial. European urology, 66(5), pp. 799-802. Elsevier 10.1016/j.eururo.2014.05.038
